BENITIONSClinical Trial Intelligence

A Study in Healthy Men to Test How Different Doses of BI 3000202 Are Tolerated and How Food Influences the Amount of BI 3000202 in the Blood

Phase 1 Completed NCT05945888

ConditionHealthy
PhasePhase 1
SponsorBoehringer Ingelheim
StatusCompleted
Enrollment68 participants
InterventionsBI 3000202, Placebo matching BI 3000202
Start dateJul 25, 2023
Completion dateNov 13, 2023
Results postedJun 8, 2026

Summary

The single rising dose (SRD) part of the trial investigates safety, tolerability, and pharmacokinetics of BI 3000202. The food effect (FE) part is conducted to assess the effect of food on the relative bioavailability of the BI 3000202 formulation.

SRD Part: Number of Any Treatment-emergent Adverse Event Assessed as Drug-related by the Investigator

From drug administration on Day 1 plus REP of 48 hours, up to 2 days. · Participants

Single Rising Dose (SRD): Placebo Matching BI 30002021 Participants
SRD: Dose 1 - BI 30002020 Participants
SRD: Dose 2 - BI 30002020 Participants
SRD: Dose 3 - BI 30002021 Participants
SRD: Dose 4 - BI 30002020 Participants
SRD: Dose 5 - BI 30002020 Participants

FE Part: Area Under the Concentration-time Curve of BI 3000202 in Plasma Over the Dosing Interval 0 to 24 Hours (AUC0-24)

Within 3 hours (h) prior to and 0.25, 0.5, 0.75, 1, 1.5, 2, 2.5, 3, 4, 5, 6, 8, 12, 24, and 48 h after drug administration · Nanomoles times hour per Liter

Food Effect (FE): Low Dose III BI 3000202 Fasted (= Reference R)901.43 ± NA Nanomoles times hour per Liter
FE Part: Low Dose III BI 3000202 Fed (= Test T)768.45 ± NA Nanomoles times hour per Liter
Geometric mean ratio (T/R) [%]85.25 (95% CI 71.74–101.30)

FE Part: Maximum Measured Concentration of BI 3000202 in Plasma (Cmax)

Within 3 hours (h) prior to and 0.25, 0.5, 0.75, 1, 1.5, 2, 2.5, 3, 4, 5, 6, 8, 12, 24, and 48 h after drug administration · Nanomoles per Liter

Food Effect (FE): Low Dose III BI 3000202 Fasted (= Reference R)229.43 ± NA Nanomoles per Liter
FE Part: Low Dose III BI 3000202 Fed (= Test T)219.06 ± NA Nanomoles per Liter
Geometric mean ratio (T/R) [%]95.48 (95% CI 65.40–139.41)

Open in BENITIONS View on ClinicalTrials.gov

All trials

This page summarises publicly available data from ClinicalTrials.gov. It is not medical advice and not investment advice. Always consult a qualified healthcare professional.